The use of plastics has become deeply ingrained in our society, and there are no indications that its prevalence will decrease in the foreseeable future. This article provides a comprehensive overview of the global plastic waste disposal landscape, examining it through regional perspectives, various management technologies (dumping or landfilling, incineration, and reuse and recycling), and across different sectors including agriculture and food, textile, tourism, and healthcare. Notably, this study compiles the findings on life-cycle carbon footprints associated with various plastic waste management practices as documented in the literature. Employing the bio-circular-green economy model, we advocate for the adoption of streamlined and sustainable approaches to plastic management. Unique management measures are also discussed including the utilization of bioplastics combined with smart and efficient collection processes that facilitate recycling, industrial composting, or anaerobic digestion. Moreover, the integration of advanced recycling methods for conventional plastics with renewable energy, the establishment of plastic tax and credits, and the establishment of extended producer responsibility are reviewed. The success of these initiatives relies on collaboration and support from peers, industries, and consumers, ultimately contributing to informed decision-making and fostering sustainable practices in plastic waste management.
The immune system is a complex network of specialized cells and organs that recognises and reacts against foreign pathogens while remaining unresponsive to host tissues. This ability to self-tolerate is known as immunological tolerance. Autoimmune disease occurs when the immune system fails to differentiate between self and non-self antigens and releases autoantibodies to attack our own cells. Anti-idiotypic (anti-ID) antibodies are important in maintaining a balanced idiotypic regulatory network by neutralising and inhibiting the secretion of autoantibodies. Recently, anti-ID antibodies have been advanced as an alternative form of immunotherapy as they can specifically target autoantibodies, cause less toxicity and side effects, and could provide long-lasting immunity. This review article discusses the immunomodulatory potential of anti-ID antibodies for the treatment of autoimmune diseases.
Blood-brain barrier (BBB) is a term describing the highly selective barrier formed by the endothelial cells (ECs) of the central nervous system (CNS) homeostasis by restricting movement across the BBB. An intact BBB is critical for normal brain functions as it maintains brain homeostasis, modulates immune cell transport, and provides protection against pathogens and other foreign substances. However, it also prevents drugs from entering the CNS to treat neurodegenerative diseases. Stem cells, on the other hand, have been reported to bypass the BBB and successfully home to their target in the brain and initiate repair, making them a promising approach in cellular therapy, especially those related to neurodegenerative disease. This review article discusses the mechanism behind the successful homing of stem cells to the brain, their potential role as a drug delivery vehicle, and their applications in neurodegenerative diseases.